Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 20603072)

1.

The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.

Krishnakumar R, Kraus WL.

Mol Cell. 2010 Jul 9;39(1):8-24. doi: 10.1016/j.molcel.2010.06.017. Review.

2.
3.

PARP-1 and gene regulation: progress and puzzles.

Kraus WL, Hottiger MO.

Mol Aspects Med. 2013 Dec;34(6):1109-23. doi: 10.1016/j.mam.2013.01.005. Epub 2013 Jan 26. Review.

PMID:
23357755
4.

Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

Kim MY, Zhang T, Kraus WL.

Genes Dev. 2005 Sep 1;19(17):1951-67. Review.

5.

On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

Luo X, Kraus WL.

Genes Dev. 2012 Mar 1;26(5):417-32. doi: 10.1101/gad.183509.111. Review.

6.

Poly(ADP-ribose) polymerase inhibitors.

Southan GJ, Szabó C.

Curr Med Chem. 2003 Feb;10(4):321-40. Review.

PMID:
12570705
7.

Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.

Horvath EM, Szabó C.

Drug News Perspect. 2007 Apr;20(3):171-81. Review.

PMID:
17520094
8.

Toward specific functions of poly(ADP-ribose) polymerase-2.

Yélamos J, Schreiber V, Dantzer F.

Trends Mol Med. 2008 Apr;14(4):169-78. doi: 10.1016/j.molmed.2008.02.003. Epub 2008 Mar 18. Review.

PMID:
18353725
9.

Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

D'Amours D, Desnoyers S, D'Silva I, Poirier GG.

Biochem J. 1999 Sep 1;342 ( Pt 2):249-68. Review.

10.

[Poly(ADP-ribose) polymerase (PARP): physiological and pathological roles].

Makogon NV, Aleksieieva IM.

Fiziol Zh. 2012;58(3):95-112. Review. Ukrainian.

PMID:
22946318
11.

PARPs and the DNA damage response.

Sousa FG, Matuo R, Soares DG, Escargueil AE, Henriques JA, Larsen AK, Saffi J.

Carcinogenesis. 2012 Aug;33(8):1433-40. doi: 10.1093/carcin/bgs132. Epub 2012 Mar 19. Review.

12.

Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis.

Tong WM, Cortes U, Wang ZQ.

Biochim Biophys Acta. 2001 Nov 30;1552(1):27-37. Review.

PMID:
11781113
13.

Importance of poly(ADP-ribose) polymerases in the regulation of DNA-dependent processes.

Petermann E, Keil C, Oei SL.

Cell Mol Life Sci. 2005 Apr;62(7-8):731-8. Review.

PMID:
15868398
14.

Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation.

Kraus WL.

Curr Opin Cell Biol. 2008 Jun;20(3):294-302. doi: 10.1016/j.ceb.2008.03.006. Epub 2008 Apr 29. Review.

16.

Poly ADP-ribose polymerase-1 and health.

Kirkland JB.

Exp Biol Med (Maywood). 2010 May;235(5):561-8. doi: 10.1258/ebm.2010.009280. Review.

PMID:
20463295
17.

[Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].

Boulu RG, Mesenge C, Charriaut-Marlangue C, Verrecchia C, Plotkine M.

Bull Acad Natl Med. 2001;185(3):555-63; discussion 564-5. Review. French.

PMID:
11501263
18.
19.

Targeting poly(ADP-ribose) polymerase activity for cancer therapy.

Mégnin-Chanet F, Bollet MA, Hall J.

Cell Mol Life Sci. 2010 Nov;67(21):3649-62. doi: 10.1007/s00018-010-0490-8. Epub 2010 Aug 20. Review.

20.

Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.

Komjáti K, Besson VC, Szabó C.

Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):179-94. Review.

PMID:
15857303
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk